| Working Paper |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| Africa's Prospects for Enjoying a Demographic Dividend |
0 |
0 |
0 |
68 |
0 |
2 |
19 |
128 |
| Africa’s Prospects for Enjoying a Demographic Dividend |
0 |
0 |
0 |
19 |
0 |
1 |
23 |
98 |
| Africa’s Prospects for Enjoying a Demographic Dividend |
0 |
0 |
0 |
20 |
0 |
3 |
35 |
150 |
| Africa’s Prospects for Enjoying a Demographic Dividend |
0 |
0 |
0 |
16 |
0 |
0 |
19 |
80 |
| Asymmetric information in the regulation of the access to markets |
0 |
0 |
0 |
49 |
0 |
0 |
26 |
153 |
| Asymmetric information in the regulation of the access to markets |
0 |
0 |
1 |
45 |
2 |
3 |
14 |
205 |
| Delegating Budgets when Agents Care About Autonomy |
0 |
0 |
0 |
44 |
0 |
2 |
14 |
376 |
| Demographic and geographic determinants of regional physician supply |
0 |
0 |
0 |
199 |
0 |
0 |
10 |
778 |
| Direct to Consumer Advertising in Pharmaceutical Markets |
0 |
0 |
0 |
569 |
0 |
2 |
15 |
2,602 |
| Direct-to-Consumer Advertising in Pharmaceutical Markets |
0 |
0 |
1 |
17 |
0 |
0 |
4 |
103 |
| Direct-to-Consumer Advertising in Pharmaceutical Markets |
0 |
0 |
2 |
410 |
0 |
0 |
11 |
1,842 |
| Does human capital compensate for depopulation? |
0 |
0 |
1 |
1 |
0 |
1 |
15 |
15 |
| Ecological dumping and environmental capital flight: The economics behind the propaganda |
0 |
0 |
0 |
11 |
0 |
1 |
7 |
83 |
| Electricity use of automation or how to tax robots? |
0 |
0 |
1 |
20 |
2 |
4 |
18 |
46 |
| Electricity use of automation or how to tax robots? |
0 |
0 |
1 |
15 |
0 |
0 |
20 |
44 |
| Environmental Policy, Firm Location, And Product Differentiation: The Role of Green Preferences and Inter-firm Pollution |
0 |
0 |
0 |
53 |
0 |
0 |
10 |
310 |
| Externalities in a Life-Cycle Model with Endogenous Survival |
0 |
0 |
0 |
47 |
2 |
2 |
16 |
185 |
| Fertility in High-Income Countries: Trends, Patterns, Determinants, and Consequences |
0 |
0 |
1 |
41 |
1 |
42 |
86 |
165 |
| Green Lemons - Environmental Labels and Entry into an Environmentally Differentiated Market under Asymmetric Information |
0 |
0 |
0 |
239 |
0 |
1 |
13 |
775 |
| Growth and Welfare Effects of Health Care in Knowledge Based Economies |
0 |
0 |
0 |
78 |
1 |
2 |
19 |
303 |
| Growth and Welfare Effects of Health Care in Knowledge Based Economies |
0 |
0 |
0 |
43 |
1 |
6 |
20 |
163 |
| Growth and welfare e ffects of health care in knowledge based economies |
0 |
0 |
1 |
45 |
0 |
1 |
25 |
213 |
| Growth and welfare effects of health care in knowledge based economies |
0 |
0 |
0 |
66 |
2 |
5 |
16 |
204 |
| Health and Economic Growth |
0 |
0 |
9 |
170 |
1 |
8 |
63 |
507 |
| Health insurance, endogenous medical progress, and health expenditure growth |
1 |
1 |
1 |
104 |
1 |
2 |
17 |
267 |
| Low Quality Leadership in Vertically Differentiated Duopoly |
0 |
0 |
0 |
309 |
0 |
3 |
9 |
1,084 |
| Medical Care within an OLG Economy with Realistic Demography |
0 |
0 |
0 |
64 |
1 |
2 |
26 |
128 |
| Medical Progress, Demand for Health Care, and Economic Performance |
0 |
0 |
0 |
32 |
0 |
1 |
12 |
105 |
| Medical care within an OLG economy with realistic demography |
0 |
0 |
0 |
66 |
0 |
3 |
18 |
180 |
| Medical innovation, life expectancy, and economic growth |
0 |
0 |
1 |
16 |
1 |
6 |
35 |
58 |
| Medical innovation, life expectancy, and economic growth |
0 |
0 |
0 |
8 |
2 |
2 |
73 |
103 |
| Medical progress, demand for health care, and economic performance |
0 |
0 |
1 |
30 |
0 |
3 |
19 |
94 |
| Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses |
0 |
0 |
0 |
23 |
0 |
0 |
15 |
148 |
| Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses |
0 |
0 |
0 |
16 |
3 |
6 |
39 |
140 |
| Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses |
0 |
0 |
0 |
17 |
0 |
0 |
14 |
81 |
| Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses |
0 |
0 |
1 |
33 |
1 |
2 |
30 |
121 |
| On the long-run growth effect of raising the retirement age |
0 |
0 |
0 |
43 |
0 |
1 |
11 |
89 |
| Optimal Choice of Health and Retirement in a Life-Cycle Model |
0 |
0 |
0 |
25 |
0 |
0 |
42 |
169 |
| Optimal choice of health and retirement in a life-cycle model |
0 |
0 |
0 |
87 |
1 |
3 |
15 |
214 |
| Performance Indicators for Quality with Adverse Selection, Gaming and Inequality Aversion |
0 |
0 |
0 |
116 |
0 |
0 |
14 |
594 |
| Population Structure and Consumption Growth: Evidence from National Transfer Accounts |
0 |
0 |
0 |
45 |
0 |
1 |
21 |
104 |
| Population structure and consumption growth: Evidence from National Transfer Accounts |
0 |
0 |
0 |
44 |
1 |
1 |
12 |
148 |
| Quality in Primary Care: Economic Approaches to Analysing Quality-Related Physician Behaviour |
0 |
0 |
0 |
28 |
1 |
1 |
5 |
79 |
| Quality monitoring, collusion and sub-contracting |
0 |
0 |
0 |
76 |
0 |
1 |
11 |
340 |
| Rising longevity, increasing the retirement age, and the consequences for knowledge-based long-run growth |
0 |
0 |
2 |
68 |
0 |
0 |
29 |
141 |
| Rising longevity, increasing the retirement age, and the consequences for knowledge-based long-run growth |
1 |
1 |
1 |
40 |
2 |
2 |
20 |
76 |
| Saving the public from the private? Incentives and outcomes in dual practice |
0 |
0 |
0 |
36 |
0 |
1 |
17 |
153 |
| The Contribution of Female Health to Economic Development |
0 |
1 |
2 |
100 |
1 |
5 |
34 |
383 |
| The Contribution of Female Health to Economic Development |
0 |
0 |
0 |
31 |
0 |
2 |
18 |
101 |
| The Economic Burden of Chronic Diseases: Estimates and Projections for China, Japan and South Korea |
0 |
0 |
2 |
67 |
0 |
1 |
59 |
201 |
| The Economic Burden of Chronic Diseases: Estimates and Projections for China, Japan, and South Korea |
0 |
0 |
1 |
26 |
0 |
4 |
18 |
157 |
| The Reproductive Value as Part of the Shadow Price of Population |
0 |
0 |
0 |
14 |
0 |
0 |
7 |
133 |
| The Reproductive Value in Distributed Optimal Control Models |
0 |
0 |
0 |
24 |
0 |
0 |
8 |
157 |
| The contribution of female health to economic development |
0 |
0 |
0 |
59 |
0 |
2 |
20 |
127 |
| The contribution of female health to economic development |
0 |
0 |
0 |
74 |
0 |
1 |
20 |
158 |
| The contribution of female health to economic development |
0 |
0 |
0 |
62 |
0 |
1 |
15 |
137 |
| The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea |
0 |
0 |
0 |
59 |
0 |
0 |
9 |
295 |
| Upcoding and Optimal Auditing in Health Care (or The economics of DRG creep) |
0 |
0 |
0 |
215 |
0 |
1 |
14 |
936 |
| Using age-structure for a multi-stage optimal control model with random switching time |
0 |
0 |
0 |
5 |
0 |
1 |
18 |
55 |
| Total Working Papers |
2 |
3 |
30 |
4,347 |
27 |
145 |
1,262 |
16,984 |
| Journal Article |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| AFRICA'S PROSPECTS FOR ENJOYING A DEMOGRAPHIC DIVIDEND |
1 |
1 |
1 |
5 |
1 |
2 |
18 |
51 |
| Access to health care, medical progress and the emergence of the longevity gap: A general equilibrium analysis |
0 |
0 |
0 |
7 |
0 |
0 |
11 |
58 |
| Africa’s Prospects for Enjoying a Demographic Dividend |
0 |
1 |
2 |
42 |
4 |
7 |
38 |
245 |
| Chasing up and locking down the virus: Optimal pandemic interventions within a network |
0 |
0 |
0 |
1 |
0 |
0 |
9 |
12 |
| Congestion in a public health service: A macro approach |
0 |
0 |
2 |
18 |
0 |
1 |
12 |
47 |
| Direct to consumer advertising in pharmaceutical markets |
0 |
0 |
0 |
114 |
2 |
2 |
9 |
345 |
| Does human capital compensate for population decline? |
0 |
0 |
2 |
5 |
0 |
0 |
19 |
50 |
| Electricity Use of Automation or How to Tax Robots? |
0 |
1 |
6 |
6 |
1 |
4 |
17 |
17 |
| Externalities in a life cycle model with endogenous survival |
0 |
0 |
0 |
15 |
0 |
1 |
11 |
97 |
| Fertility in High-Income Countries: Trends, Patterns, Determinants, and Consequences |
0 |
0 |
5 |
12 |
0 |
5 |
63 |
93 |
| Forest loss and uncertain economic gains from industrial and garimpo mining in Brazilian municipalities |
0 |
0 |
0 |
0 |
0 |
0 |
9 |
9 |
| Growth and welfare effects of health care in knowledge-based economies |
0 |
1 |
2 |
73 |
3 |
5 |
21 |
237 |
| Health insurance, endogenous medical progress, health expenditure growth, and welfare |
0 |
0 |
2 |
7 |
2 |
2 |
16 |
32 |
| Health, education, and retirement over the prolonged life cycle: a selective survey of recent research |
0 |
0 |
0 |
0 |
0 |
2 |
48 |
63 |
| Integrating large health shocks into life-cycle models - modelling impacts of a cancer diagnosis |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Justice considerations in climate research |
0 |
1 |
7 |
33 |
1 |
4 |
24 |
67 |
| Macro-level efficiency of health expenditure: Estimates for 15 major economies |
0 |
0 |
1 |
6 |
0 |
1 |
16 |
39 |
| Manipulation and auditing of public sector contracts |
1 |
3 |
4 |
33 |
1 |
4 |
23 |
163 |
| Medical innovation and its diffusion: Implications for economic performance and welfare |
0 |
1 |
2 |
21 |
3 |
5 |
15 |
77 |
| Minimum quality standards and market dominance in vertically differentiated duopoly |
0 |
0 |
1 |
76 |
0 |
2 |
11 |
200 |
| Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses |
0 |
0 |
4 |
74 |
0 |
4 |
21 |
220 |
| On the Anatomy of Medical Progress Within an Overlapping Generations Economy |
0 |
0 |
0 |
12 |
1 |
1 |
15 |
55 |
| Optimal choice of health and retirement in a life-cycle model |
0 |
0 |
1 |
59 |
1 |
2 |
20 |
190 |
| Optimal public provision of nursing homes and the role of information |
0 |
0 |
0 |
57 |
0 |
2 |
12 |
254 |
| Performance Indicators for Quality with Costly Falsification |
0 |
0 |
0 |
39 |
1 |
3 |
11 |
123 |
| Population age structure and consumption growth: evidence from National Transfer Accounts |
0 |
0 |
2 |
48 |
1 |
2 |
21 |
222 |
| Population change and the regional distribution of physicians |
0 |
0 |
0 |
5 |
0 |
2 |
14 |
48 |
| Recognizing progeny in the value of life |
0 |
0 |
0 |
13 |
0 |
1 |
19 |
127 |
| Riding the waves from epidemic to endemic: Viral mutations, immunological change and policy responses |
0 |
0 |
1 |
1 |
0 |
1 |
15 |
20 |
| Rising Longevity, Increasing the Retirement Age, and the Consequences for Knowledge‐based Long‐run Growth |
0 |
0 |
0 |
13 |
2 |
5 |
18 |
58 |
| Saving the public from the private? Incentives and outcomes in dual practice |
0 |
0 |
0 |
1 |
1 |
2 |
15 |
31 |
| Special issue: 100th anniversary of the Austrian Economic Association and the Future of Health Care Systems |
0 |
0 |
0 |
0 |
1 |
1 |
10 |
22 |
| Subnational survey data reveal persistent gaps in living standards across 75 low and middle-income countries |
0 |
0 |
0 |
0 |
1 |
2 |
10 |
10 |
| The contribution of female health to economic development |
0 |
0 |
0 |
21 |
0 |
3 |
27 |
98 |
| The economic burden of COVID-19 in the United States: Estimates and projections under an infection-based herd immunity approach |
0 |
0 |
0 |
1 |
0 |
0 |
9 |
32 |
| The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea |
0 |
0 |
5 |
49 |
2 |
4 |
39 |
226 |
| The hammer and the jab: Are COVID-19 lockdowns and vaccinations complements or substitutes? |
0 |
0 |
0 |
1 |
0 |
0 |
15 |
27 |
| The macroeconomic burden of noncommunicable diseases in the United States: Estimates and projections |
0 |
0 |
1 |
4 |
0 |
1 |
23 |
47 |
| The reproductive value as part of the shadow price of population |
0 |
0 |
0 |
11 |
0 |
1 |
3 |
73 |
| The reproductive value in distributed optimal control models |
0 |
0 |
0 |
0 |
0 |
0 |
8 |
19 |
| Using Age Structure for a Multi-stage Optimal Control Model with Random Switching Time |
0 |
0 |
0 |
3 |
0 |
1 |
9 |
32 |
| Total Journal Articles |
2 |
9 |
51 |
886 |
29 |
85 |
724 |
3,836 |